Welcome : Guest

Concert Pharmaceuticals, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Concert Pharmaceuticals, Inc., which is principally involved in Clinical-Stage Biopharmaceuticals Business. Illustrated with 75 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-64112
Price: $3500
Company Type: Public
Pages: 78
Date: November 2016
Market Data Tables: 75

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Central Nervous System (CNS) Drugs......4
Table 1: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......4
Table 2: Central Nervous System Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......5
Chronic Obstructive Pulmonary Disease (COPD) Drugs......6
Table 3: Chronic Obstructive Pulmonary Disease (COPD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, North America and Rest of the World......6
Table 4: Chronic Obstructive Pulmonary Disease (COPD) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Long Acting Muscarinic Antagonists (LAMA), Long Acting Muscarinic Antagonists (LAMA) and Long Acting β2-Agonists (LABA), and Long Acting β2-Agonists (LABA) and Inhaled Corticosteroid (ICS)......7
Table 5: No. of Chronic Obstructive Pulmonary Disease (COPD) Patients Worldwide (2015) - Percentage Market Share Breakdown for Europe, North America, and Rest of World......8
Table 6: Chronic Obstructive Pulmonary Disease (COPD) and Asthma Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Flixotide and Flovent, Seretide and Advair, Spiriva, Symbicort, Xolair, and Others......9
Cancer Drugs......10
Table 7: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......10
Table 8: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......11
Cancer Market......12
Table 9: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......12
Table 10: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......13
Table 11: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......14
Table 12: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......15
Table 13: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......16
Table 14: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......17
Table 15: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......18
Table 16: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......19
Cervical Cancer......20
Table 17: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......20
Table 18: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......21
Hematological Cancer......22
Table 19: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......22
Skin Cancer......23
Table 20: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......23
Cancer-Associated Mucositis......24
Table 21: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......24
Chronic Myelogenous Leukemia (CML)......25
Table 22: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......25
Multiple Myeloma......26
Table 23: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......26
Table 24: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......27
Dermatological Drugs......28
Table 25: Dermatological Drug Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Acne, Alopecia, Atopic Dermatitis, Herpes, Psoriasis, Rosacea, Skin Cancer, and Skin Infections......28
Table 26: Dermatology Drugs Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Italy, Japan, Spain, UK, US, and Rest of World......29
Table 27: Dermatology Market by Category in the US (2015) - Percentage Share Breakdown by Value for Genericised, Off-Patent but No Generics, On-Patent, and Others......30
Table 28: Dermal Substitutes Chronic Wound Market by Category in the US (2015) - Percentage Share Breakdown by Value for Diabetic Foot Ulcer, Pressure Ulcer and Venous Leg Ulcer......31
Table 29: Prevalence & Severity of Actinic Keratoses Market by Category in the US (2015) - Percentage Share Breakdown by Value for Minimal, Moderate, Severe, and Others......32
Kidney Disease Drugs......33
Table 30: Traditional Chinese Medicine (TCM) Market for Kidney Ailments by Drug in China (2015) - Percentage Share Breakdown by Value Sales for Ambrette Capsule, Haikunshenxi Capsule, Shenyankangfu Tablet, Uremic Clearance Granule, Yinhuamiyangling and Others......33
Table 31: Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......34
Table 32: Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, EPO alfa/beta biosimilars and Others......35
Table 33: Hemodialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others......36
Table 34: Chronic Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......37
Table 35: Peritoneal Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others (Includes Mircera)......38
Table 36: New Patients with Kidney Failure by Cause in the US (2015) - Percentage Share Breakdown by Volume for Diabetes, High Blood Pressure and Others......39
Narcolepsy......40
Table 37: Diagnosed Narcolepsy Patients Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Current Xyrem Patient, Untreated Diagnosed Patients and WF Peak Additional Xyrem Patients......40
Cystic Fibrosis......41
Table 38: Cystic Fibrosis (CF) Patient Population by Region Worldwide (2015) - Percentage Share Breakdown by Value for Australia, Canada, Rest of Europe, United Kingdom and USA......41
Table 39: Drugs for Treatment of Cystic Fibrosis Market Worldwide (2015) in US$ Million......42
Anti-Psychotics......43
Table 40: Anti-Psychotics Market Worldwide (2015-2020) in US$ '000......43
Table 41: Prescribed Atypical Antipsychotic Market by Type in the US (2015) – Percentage Share Breakdown by Value for 5HT1A Agonist, H1, Antagonist, D2 and 5HT2, D2 and 5HT2A, and Partial D2 Agonist......44
Table 42: Antipsychotic Drugs Market by Disorder in the US (2015) - Percentage Breakdown by Value for Anxiety, Bipolar, Disorder, Major, Depression, Schizoaffective Disorder, Schizophrenia, and Other Indications......45
Cold, Cough Remedies......46
Table 43: Cough-Cold Medication Market by Product in the US (2015) - Percentage Share Breakdown by Value for Anticholinergics, Antihistamines, Benzonatate, Expectorants, Triple Combinations and Other......46
Table 44: Cough-Cold Medication (Narcotics & Non-Norcotics) Market by Product in the US (2015) - Percentage Share Breakdown by Value for Benzonatate, Codeine, Dextromethorphan and Hydrocodone......47
Table 45: Cough and Cold Treatments Market through Supermarkets, Drug Stores, and Mass Merchandisers, (Including Wal-Mart), Military Commissaries and Select Club and Dollar Retail Chains by Type in the US (2015) - Percentage Share Breakdown by Value for Chest Rubs, Cold, Allergy, and Sinus Liquids, Cold, Allergy, and Sinus Tablets, Cough Drops, Cough Syrup, and Nasal Products......48
Table 46: Cold-Allergy-Sinus (Liquid and Powder) Market through Supermarkets, Drug Stores, Mass Merchandisers (Including Wal-Mart) in the US (2015) in US$ Million......49
Table 47: Cold-Allergy-Sinus Treatments (Liquid) Market through Supermarkets, Drug Stores, Mass Merchandisers (Including Wal-Mart), Military Commissaries and Select Club and Dollar Stores in the US (2015) in US$ Million......50
Table 48: Cold-Allergy-Sinus Treatments (Tablets and Packets) Market through Supermarkets, Drug Stores, Mass Merchandisers (Including Wal-Mart), Military Commissaries and Select Club and Dollar Stores in the US (2015) in US$ Million......51
Psoriasis......52
Table 49: Psoriasis Disease by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Palmoplantar Psoriasis, Plaque Psoriasis, Psoriasis of Mucous Membranes, Psoriatic Arthritis, and Pustular Psoriasis......52
Rheumatoid Arthritis......53
Table 50: Rheumatoid Arthritis Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and Others......53
Inflammatory Bowel Disease (IBD)......54
Table 51: Inflammatory Bowel Disease (IBD) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Anti-Inflammatory, Biologics, and Immunomodulatory......54
Central Nervous System (CNS) Medicines......55
Table 52: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......55
Table 53: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......56
Cancer Drugs......57
Table 54: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......57
Table 55: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......58
Table 56: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......59
Table 57: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......60
Table 58: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......61
Breast Cancer Drugs......62
Table 59: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......62
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......63
Table 60: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......63
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......64
Table 61: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Other......64
Table 62: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......65
Dermatological Products......66
Table 63: Market Shares of Leading Dermatological Product Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......66
Table 64: Market Shares of Leading Dermatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Biogen Idec, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, and Others......67
Table 65: Market Shares of Leading Therapeutic Dermatology (excluding Aesthetics) Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Inc. (ABBV), Galderma S.A., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Pfizer, Inc. (PFE), Amgen, Inc. (AMGN), Valeant Pharmaceuticals Intl, Inc., Dermik Laboratories, and Others......68
Table 66: Market Shares of Leading Drugs for Treatment of Skin Infection in the US (2015) - Percentage Share Breakdown by Value for CUBICIN, VANCOMYCIN, ZYVOX IV and Others......69
Alzheimer Disease Therapeutics......70
Table 67: Market Shares of Leading Alzheimer Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Forest Laboratories, Inc., Johnson & Johnson, Novartis International AG, Pfizer, Inc., and Others......70
Sleep Disorder Drugs......71
Table 68: Market Shares of Leading Sleep Disorders Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Sanofi S.A., and Others......71
Table 69: Sleep Aid Drugs Market by Product Type in the US (2015) - Percentage Share Breakdown by Prescriptions for Lunesta Generic Ambien(Sanofi), and Lunesta Generic(Sunovion)......72
Antipsychotics......73
Table 70: Anti-Psychotic Market by Drug Type Worldwide (2015) - Percentage Share Breakdown by Value for Abilify, Abilify Maintena, Invega Sustenna, Latuda, Risperdal Consta, Seroquel XR, and Others......73
Table 71: Market Shares of Leading Prescribed Atypical Antipsychotic Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Sunovion Pharmaceuticals, Inc., and Johnson & Johnson Private Limited......74
Table 72: Market Shares of Leading Prescribed Atypical Antipsychotic Brands in the US (2015) - Percentage Share Breakdown by Value for Abilify, Invega, Latuda, Risperdal, Seroquel, and Others......75
Table 73: New Prescription Market for Atypical Antipsychotic Drugs in the US (2015) - Percentage Share Breakdown by Value Sales for Abilify (Otsuka/ Bristol-Myers Squibb Company), Fanapt (Novartis), Geodon (Pfizer, Inc.), Invega (Johnson & Johnson), Latuda (Sunovion), Olanzapine (Generic Zyprexa), Risperidone (Generic Risperdal), Saphris (Merck & Company, Inc.), Seroquel (AstraZeneca Plc), and Zyprexa (Eli Lilly and Company)......76
Psoriasis......77
Table 74: Market Shares of Leading Drugs for Treatment of Psoriasis Worldwide (2015) - Percentage Share Breakdown by Value for Enbrel, Humira, Remicade, Stelara and Others......77
Anti-Inflammatory Biologics......78
Table 75: Market Shares of Leading Anti-Inflammatory Biologic Brands Worldwide (2015) - Percentage Share Breakdown by Value for Actemra, Enbrel, Humira, Remicade and Others......78